Urodynamix Appoints Corporate Secretary

VANCOUVER, British Columbia, February 19, 2007 - Urodynamix Technologies Ltd. (TSX-V:URO) today announced that Tanner W. Philp, CA has been appointed as Corporate Secretary.

Mr. Philp currently serves as Chief Financial Officer and Partner of Lions Capital Corp., the fund manager of BC Advantage Funds (VCC) Ltd., a venture capital fund that invests in emerging technology and life science companies. Mr. Philp is a Director of Vigil Health Solutions Inc. and an advisor to a number of technology companies where he works to maximize value for investors. He specializes in working with early-stage public and private companies on business strategy development, funding, mergers and acquisitions and corporate partnering.

Mr. Philp is a Chartered Accountant who began his career with KPMG Vancouver and subsequently worked for KPMG London (UK) where he specialized in providing consulting and corporate finance services. He holds a Bachelor of Business Administration in Finance from Simon Fraser University.

Urodynamix also reported today that it has issued 150,000 incentive stock options to officers and consultants of the company. The options have a term of five years, an exercise price of $0.15 per share and have been issued in conformance with TSX Venture Exchange regulations.

Urodynamix currently has outstanding 65,186,487 common shares, 16,953,905 warrants and 5,984,000 incentive stock options. The company’s Stock Option Plan allows the Board to issue the equivalent of up to 10% of the issued and outstanding share capital of the company on a rolling basis and was approved at the company’s last Annual General Meeting held on June 7, 2006.

About Urodynamix Technologies Ltd.

Urodynamix is developing a portfolio of non-invasive diagnostic products for a variety of large and growing global markets. The Company’s disruptive technology based on near-infrared spectroscopy (NIRS) has the potential to affect the diagnosis and treatment of 200 million people worldwide.

On behalf of the Board,

“Barry Allen”
President & CEO
Urodynamix Technologies Ltd.

Certain information contained in this press release may be forward-looking and is subject to unknown risks, which could cause actual results to differ materially from those set forth or implied herein. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Craig Pamplin, PhD

Director, Corporate Development and Communications

Urodynamix Technologies Ltd.

Tel: (604) 638-0247

Email: cpamplin@urodynamix.com

www.urodynamix.com